We are live on
!
Find out more
RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$9.44B
1-Year Est. Return
68.42%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$2.29B
AUM Growth
+$308M
(+16%)
Cap. Flow
+$128M
Cap. Flow
% of AUM
5.6%
Top 10 Holdings %
Top 10 Hldgs %
38.21%
Holding
106
New
19
Increased
26
Reduced
11
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xperi
XPER
|
+$44M |
| 2 |
New Fortress Energy
NFE
|
+$40.7M |
| 3 |
Arcutis Biotherapeutics
ARQT
|
+$39.7M |
| 4 |
Heron Therapeutics
HRTX
|
+$29.7M |
| 5 |
Zymeworks
ZYME
|
+$21.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adeia
ADEA
|
+$101M |
| 2 |
Apollo Global Management
APO
|
+$44.2M |
| 3 |
FerroAtlántica
GSM
|
+$36.1M |
| 4 |
Green Plains
GPRE
|
+$29.8M |
| 5 |
Hertz
HTZ
|
+$18.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.49% |
| 2 | Energy | 19.6% |
| 3 | Industrials | 18.17% |
| 4 | Technology | 7.38% |
| 5 | Financials | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
FerroAtlántica
GSM
$832M
| $12.4M | 0.54% |
3,232,762
-7,255,939
| -69% | -$36.1M |
|
52
Cenovus Energy
CVE
$55.6B
| $11M | 0.48% |
+568,600
| New | +$10.9M |
|
53
Trevi Therapeutics
TRVI
$2.53B
| $11M | 0.48% |
5,684,420
| – | – |
|
54
Lantheus
LNTH
$6.57B
| $10.9M | 0.47% |
+213,207
| New | +$13.2M |
|
55
Telesat
TSAT
$934M
| $10.6M | 0.46% |
1,410,000
| – | – |
|
56
TherapeuticsMD
TXMD
$24.1M
| $9.82M | 0.43% |
1,757,191
+600,238
| +52% | +$3.53M |
|
57
FTAI Infrastructure
FIP
$533M
| $9.42M | 0.41% |
3,193,530
| – | – |
|
58
Semtech
SMTC
$13B
| $8.88M | 0.39% |
+309,347
| New | +$8.77M |
|
59
PUT
AMC Entertainment Holdings
AMC
$2.26B
| $8.4M | 0.37% |
+206,290
| New | +$13M |
|
60
OmniAb
OABI
$497M
| $8.1M | 0.35% |
+2,249,222
| New | +$11.8M |
|
61
Arbutus Biopharma
ABUS
$907M
| $8.08M | 0.35% |
+3,466,281
| New | +$8.29M |
|
|
MREO
62
Mereo BioPharma
MREO
$48.3M
| $7.77M | 0.34% |
10,366,120
| – | – |
|
63
Nerdy
NRDY
$93.7M
| $7.76M | 0.34% |
3,450,406
| – | – |
|
64
PLAYSTUDIOS Inc
MYPS
$72.1M
| $7.61M | 0.33% |
1,961,184
| – | – |
|
65
Suncor Energy
SU
$74.7B
| $7.38M | 0.32% |
+232,558
| New | +$7.64M |
|
66
Krystal Biotech
KRYS
$9.85B
| $7.34M | 0.32% |
92,609
| – | – |
|
67
Cimpress
CMPR
$2.4B
| $7.16M | 0.31% |
+259,456
| New | +$6.73M |
|
68
Cullinan Oncology
CGEM
$1.26B
| $6.61M | 0.29% |
626,929
+67,192
| +12% | +$816K |
|
69
Laureate Education
LAUR
$5.1B
| $6.31M | 0.27% |
655,482
| – | – |
|
|
VNET
70
VNET Group
VNET
$2.11B
| $6.2M | 0.27% |
+1,093,893
| New | +$5.63M |
|
71
Cameco
CCJ
$43.1B
| $5.67M | 0.25% |
+250,000
| New | +$5.88M |
|
|
MORF
72
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $5.33M | 0.23% |
+199,264
| New | +$5.45M |
|
73
Ovintiv
OVV
$17.5B
| $5.02M | 0.22% |
+99,011
| New | +$5.17M |
|
|
NGM
74
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $4.4M | 0.19% |
877,161
| – | – |
|
75
Tarsus Pharmaceuticals
TARS
$3.07B
| $4.17M | 0.18% |
284,732
| – | – |
|
Similar funds
RCM
SIM
NPT
AC
PVI
WPL
LAMI
CCMT
Rubric Capital Management (New York)'s Q4 2022 Portfolio in Review
As of Q4 2022, Rubric Capital Management (New York) held 106 positions worth $2.29B, up 16% from $1.99B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Rubric Capital Management (New York) deployed $128M of net new capital in Q4 2022, opening 19 new positions and adding to 26 existing holdings. Its largest new stake was Xperi: 3,843,744 shares worth $33.1M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 23% a quarter earlier, followed by Energy and Industrials.
On the sell side, the largest reduction was Adeia, an estimated $101M trimmed.
- Rubric Capital Management (New York)'s largest Q4 2022 buy was Xperi: 3,843,744 shares worth $33.1M.
- Rubric Capital Management (New York) added most to New Fortress Energy in Q4 2022, an estimated $40.7M increase.
- Rubric Capital Management (New York)'s biggest Q4 2022 reduction was Adeia, cutting an estimated $101M.
- Rubric Capital Management (New York) fully exited Apollo Global Management in Q4 2022, selling an estimated $44.2M.
- Rubric Capital Management (New York)'s ten largest holdings make up 38% of its $2.29B portfolio in Q4 2022.
- Rubric Capital Management (New York) opened 19 new positions and closed 11 in Q4 2022.
- Rubric Capital Management (New York)'s portfolio value rose 16% quarter-over-quarter to $2.29B.
Based on Rubric Capital Management (New York)'s 13F filing for Q4 2022, filed 10 Feb 2023.